Develops drugs for neuroinflammation and Parkinson's disease.
Dec 2025Revenue $21.8K/yrExpenses $8.93M/yr
No trend
Figures by year
When will Jupiter Neurosciences be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $21.8K and expenses $8.93M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $21.8K | $8.93M | −$8.91M |
| Dec 2024 | $0.00 | $3.09M | −$3.09M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.